One of China's top VC firms managing $5.6B across 18 funds (9 USD, 9 RMB). Strong dual focus on technology/consumer and healthcare/biotech, with extensive track record of backing category leaders from early stage to IPO.
Auto-extracted from press releases.
Auto-detected from Qiming Venture Partners's website.
Focus and check size from the firm's website. Website reachable as of Aug 2026.
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.